Natixis Advisors, L.P. Medtronic PLC Transaction History

Natixis Advisors, L.P.

$46 Billion
Q2 2024

A detailed history of Natixis Advisors, L.P. transactions in Medtronic PLC stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,185,911 shares of MDT stock, worth $106 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,185,911

Previous 1,078,582 9.95%

Holding current value

$106 Million

Previous $94 Million 0.7%

% of portfolio

0.2%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$78.71 - $87.02 $8.45 Million - $9.34 Million	107,329 Added 9.95%	1,185,911 $93.3 Million
Q1 2024 Apr 25, 2024	BUY	$82.84 - $88.09 $1.26 Million - $1.34 Million	15,245 Added 1.43%	1,078,582 $94 Million
Q4 2023 Feb 06, 2024	BUY	$69.43 - $83.43 $5.82 Million - $6.99 Million	83,816 Added 8.56%	1,063,337 $87.6 Million
Q3 2023 Nov 13, 2023	BUY	$78.22 - $90.4 $4.34 Million - $5.01 Million	55,433 Added 6.0%	979,521 $76.8 Million
Q2 2023 Aug 15, 2023	BUY	$79.47 - $91.38 $7.33 Million - $8.42 Million	92,178 Added 11.08%	924,088 $81.4 Million
Q1 2023 May 11, 2023	BUY	$76.72 - $87.58 $26.6 Million - $30.4 Million	347,282 Added 71.66%	831,910 $67.1 Million
Q4 2022 Jan 27, 2023	SELL	$76.18 - $87.74 $19.7 Million - $22.7 Million	-258,947 Reduced 34.82%	484,628 $37.7 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $20.6 Million - $24.4 Million	255,695 Added 52.41%	743,575 $60 Million
Q2 2022 Aug 12, 2022	SELL	$87.4 - $113.09 $16.9 Million - $21.8 Million	-192,957 Reduced 28.34%	487,880 $43.8 Million
Q1 2022 May 12, 2022	SELL	$100.58 - $112.38 $6.28 Million - $7.02 Million	-62,443 Reduced 8.4%	680,837 $75.5 Million
Q4 2021 Feb 08, 2022	SELL	$99.53 - $127.75 $12.4 Million - $15.9 Million	-124,493 Reduced 14.35%	743,280 $76.9 Million
Q3 2021 Nov 15, 2021	BUY	$122.75 - $135.17 $11.8 Million - $13 Million	96,083 Added 12.45%	867,773 $109 Million
Q2 2021 Aug 12, 2021	SELL	$118.19 - $131.5 $8.27 Million - $9.2 Million	-69,987 Reduced 8.32%	771,690 $95.8 Million
Q1 2021 May 05, 2021	BUY	$111.18 - $119.74 $3.4 Million - $3.66 Million	30,587 Added 3.77%	841,677 $99.4 Million
Q4 2020 Feb 12, 2021	SELL	$100.57 - $117.14 $2.24 Million - $2.61 Million	-22,267 Reduced 2.67%	811,090 $95 Million
Q3 2020 Nov 12, 2020	BUY	$90.13 - $108.78 $4.09 Million - $4.93 Million	45,327 Added 5.75%	833,357 $86.6 Million
Q2 2020 Aug 11, 2020	BUY	$84.11 - $103.33 $1.51 Million - $1.85 Million	17,931 Added 2.33%	788,030 $72.3 Million
Q1 2020 Apr 27, 2020	SELL	$72.92 - $121.3 $6.49 Million - $10.8 Million	-88,938 Reduced 10.35%	770,099 $69.4 Million
Q4 2019 Feb 10, 2020	BUY	$104.49 - $114.54 $6.3 Million - $6.9 Million	60,247 Added 7.54%	859,037 $97.5 Million
Q3 2019 Nov 12, 2019	BUY	$98.02 - $111.18 $6.74 Million - $7.64 Million	68,739 Added 9.42%	798,790 $86.8 Million
Q2 2019 Aug 12, 2019	BUY	$84.15 - $99.38 $3.85 Million - $4.55 Million	45,798 Added 6.69%	730,051 $71.1 Million
Q1 2019 May 15, 2019	BUY	$82.45 - $93.79 $4.48 Million - $5.1 Million	54,394 Added 8.64%	684,253 $62.3 Million
Q4 2018 Feb 13, 2019	BUY	$85.8 - $99.49 $420,849 - $487,998	4,905 Added 0.78%	629,859 $57.3 Million
Q3 2018 Nov 13, 2018	BUY	$85.91 - $99.17 $473,879 - $547,021	5,516 Added 0.89%	624,954 $61.5 Million
Q2 2018 Aug 14, 2018	SELL	$77.48 - $87.83 $9.59 Million - $10.9 Million	-123,771 Reduced 16.65%	619,438 $0
Q1 2018 May 10, 2018	BUY	$76.55 - $87.26 $2.64 Million - $3.01 Million	34,443 Added 4.86%	743,209 $59.6 Million
Q4 2017 Feb 14, 2018	BUY	$76.93 - $83.5 $12 Million - $13 Million	156,175 Added 28.26%	708,766 $57.2 Million
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $42.9 Million - $46.7 Million	552,591	552,591 $43 Million

Others Institutions Holding MDT

# of Institutions

2,243

Shares Held

1.04B

Call Options Held

7.1M

Put Options Held

4.42M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $119B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Medtronic PLC Transaction History